Efficacy of hyperbaric oxygen therapy combined with mild hyperthermia for improving the anti-tumour effects of carboplatin

References

• Jones EL, Samulski TV, Leonard RP, Dewhirst MW. Hyperthermia, 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins, 2003
   Google Scholar
• Moyer HR, Delman KA. The role of hyperthermia in optimizing tumor response to regional therapy. Int J Hyperthermia 2008;24:251–61
   PubMed Web of Science ®Google Scholar
• Song CW, Shakil A, Osborn JL, Iwata K. Tumour oxygenation is increased by hyperthermia at mild temperatures. Int J Hyperthermia 1996;12:367–73
   PubMed Web of Science ®Google Scholar
• Song CW, Park H, Griffin RJ. Improvement of tumor oxygenation by mild hyperthermia. Radiat Res 2001;155:515–28
   PubMed Web of Science ®Google Scholar
• Zhao C, Dai C, Chen X. Whole-body hyperthermia combined with hyperthermic intraperitoneal chemotherapy for the treatment of stage IV advanced gastric cancer. Int J Hyperthermia 2012;28:735–41
   PubMed Web of Science ®Google Scholar
• Huang T, Gong W, Li X, Zou C, Jiang G, Feng D. Enhancement of osteosarcoma cell sensitivity to cisplatin using paclitaxel in the presence of hyperthermia. Int J Hyperthermia 2013;29:248–55
   PubMed Web of Science ®Google Scholar
• Heijkoop ST, van Doorn HC, Stalpers LJ, Boere IA, van der Velden J, Franckena M, et al. Results of concurrent chemotherapy and hyperthermia in patients with recurrent cervical cancer after previous chemoradiation. Int J Hyperthermia 2014;30:6–10
   PubMed Web of Science ®Google Scholar
• Tschoep-Lechner KE, Milani V, Berger F, Dieterle N, Abdel-Rahman S, Salat C, et al. Gemcitabine and cisplatin combined with regional hyperthermia as second-line treatment in patients with gemcitabine-refractory advanced pancreatic cancer. Int J Hyperthermia 2013;29:8–16
   PubMed Web of Science ®Google Scholar
• Yarema RR, Ohorchak MA, Zubarev GP, Mylyan YP, Oliynyk YY, Zubarev MG, et al. Hyperthermic intraperitoneal chemoperfusion in combined treatment of locally advanced and disseminated gastric cancer: Results of a single-centre retrospective study. Int J Hyperthermia 2014;30:159–65
   PubMed Web of Science ®Google Scholar
• Sousa A, Inman BA, Pineiro I, Monserrat V, Perez A, Aparici V, et al. A clinical trial of neoadjuvant hyperthermic intravesical chemotherapy (HIVEC) for treating intermediate and high-risk non-muscle invasive bladder cancer. Int J Hyperthermia 2014;30:166–70
   PubMed Web of Science ®Google Scholar
• Inman BA, Stauffer PR, Craciunescu OA, Maccarini PF, Dewhirst MW, Vujaskovic Z. A pilot clinical trial of intravesical mitomycin-C and external deep pelvic hyperthermia for non-muscle-invasive bladder cancer. Int J Hyperthermia 2014;30:171–5
   PubMed Web of Science ®Google Scholar
• Xu MJ, Alberts DS. Potentiation of platinum analogue cytotoxicity by hyperthermia. Cancer Chemother Pharmacol 1988;21:191–6
   PubMed Web of Science ®Google Scholar
• Herman TS, Teicher BA, Chan V, Collins LS, Abrams MJ. Effect of heat on the cytotoxicity and interaction with DNA of a series of platinum complexes. Int J Radiat Oncol Biol Phys 1989;16:443–9
   PubMed Web of Science ®Google Scholar
• Moen I, Stuhr LE. Hyperbaric oxygen therapy and cancer – a review. Target Oncol 2012;7:233–42
   PubMed Web of Science ®Google Scholar
• Brizel DM, Lin S, Johnson JL, Brooks J, Dewhirst MW, Piantadosi CA. The mechanisms by which hyperbaric oxygen and carbogen improve tumour oxygenation. Br J Cancer 1995;72:1120–4
   PubMed Web of Science ®Google Scholar
• Kinoshita Y, Kohshi K, Kunugita N, Tosaki T, Yokota A. Preservation of tumour oxygen after hyperbaric oxygenation monitored by magnetic resonance imaging. Br J Cancer 2000;82:88–92
   PubMed Web of Science ®Google Scholar
• Kawasoe Y, Yokouchi M, Ueno Y, Iwaya H, Yoshida H, Komiya S. Hyperbaric oxygen as a chemotherapy adjuvant in the treatment of osteosarcoma. Oncol Rep 2009;22:1045–50
   PubMed Web of Science ®Google Scholar
• Suzuki Y, Tanaka K, Neghishi D, Shimizu M, Murayama N, Hashimoto T, et al. Increased distribution of carboplatin, an anti-cancer agent, to rat brains with the aid of hyperbaric oxygenation. Xenobiotica 2008;38:1471–5
   PubMed Web of Science ®Google Scholar
• Ohguri T, Imada H, Narisada H, Yahara K, Morioka T, Nakano K, et al. Systemic chemotherapy using paclitaxel and carboplatin plus regional hyperthermia and hyperbaric oxygen treatment for non-small cell lung cancer with multiple pulmonary metastases: Preliminary results. Int J Hyperthermia 2009;25:160–7
   PubMed Web of Science ®Google Scholar
• Cohen JD, Robins HI, Schmitt CL. Tumoricidal interactions of hyperthermia with carboplatin, cisplatin and etoposide. Cancer Lett 1989;44:205–10
   PubMed Web of Science ®Google Scholar
• Ohno S, Siddik ZH, Baba H, Stephens LC, Strebel FR, Wondergem J, et al. Effect of carboplatin combined with whole body hyperthermia on normal tissue and tumor in rats. Cancer Res 1991;51:2994–3000
   PubMed Web of Science ®Google Scholar
• Sakaguchi Y, Makino M, Kaneko T, Stephens LC, Strebel FR, Danhauser LL, et al. Therapeutic efficacy of long duration-low temperature whole body hyperthermia when combined with tumor necrosis factor and carboplatin in rats. Cancer Res 1994;54:2223–7
   PubMed Web of Science ®Google Scholar
• Selvendiran K, Kuppusamy ML, Ahmed S, Bratasz A, Meenakshisundaram G, Rivera BK, et al. Oxygenation inhibits ovarian tumor growth by downregulating STAT3 and cyclin-D1 expressions. Cancer Biol Ther 2010;10:386–90
   PubMed Web of Science ®Google Scholar
• Teicher BA, Lazo JS, Sartorelli AC. Classification of antineoplastic agents by their selective toxicities toward oxygenated and hypoxic tumor cells. Cancer Res 1981;41:73–81
   PubMed Web of Science ®Google Scholar
• Donnelly ET, Kelley M, Rockwell S. Effects of RSR13 and oxygen on the cytotoxicity of cisplatin and carboplatin to EMT6 mouse mammary tumor cells in vitro and in vivo. Cancer Chemother Pharmacol 2004;53:43–50
   PubMed Web of Science ®Google Scholar
• Koch S, Mayer F, Honecker F, Schittenhelm M, Bokemeyer C. Efficacy of cytotoxic agents used in the treatment of testicular germ cell tumours under normoxic and hypoxic conditions in vitro. Br J Cancer 2003;89:2133–9
   PubMed Web of Science ®Google Scholar
• Griffin RJ, Okajima K, Barrios B, Song CW. Mild temperature hyperthermia combined with carbogen breathing increases tumor partial pressure of oxygen (pO2) and radiosensitivity. Cancer Res 1996;56:5590–3
   PubMed Web of Science ®Google Scholar